UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

EUROPEAN PSYCHIATRY, 2007, Vol.22, p.S5-S6

2007

Volltextzugriff (PDF)

Niacin skin-flush response and with schizophrenia electrodermal activity in patients and healthy controls

Prostaglandins, leukotrienes and essential fatty acids, 2006-05, Vol.74 (5), p.339

2006

Volltextzugriff (PDF)

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Psychopharmacology, 1995-10, Vol.121 (3), p.309-316

1995

Volltextzugriff (PDF)

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Acta psychiatrica Scandinavica, 1989-08, Vol.80 (S352), p.30-34

1989

Volltextzugriff (PDF)

Schizophrenia as a systemic disorder — studies of peripheral and central biological functions

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.219-219

2002

Volltextzugriff (PDF)

Muscle histopathology in schizophrenia

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.45-45

2002

Volltextzugriff (PDF)

Aberrant tyrosine transport across the cell membrane in schizophrenia

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.75-75

2002

Volltextzugriff (PDF)

Aberrant fingertapping and electromyographical abnormalities in patients with schizophrenia

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.45-45

2002

Volltextzugriff (PDF)

Muscle biopsy, macro EMG and clinical characteristics in patients with schizophrenia

SCHIZOPHRENIA RESEARCH, 2000, Vol.41 (1), p.156-156

2000

Volltextzugriff (PDF)

Association study and meta-analysis of a DRD3 gene Ser9Gly variant and schizophrenia

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.182-182

2002

Volltextzugriff (PDF)

Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and normals

SCHIZOPHRENIA RESEARCH, 1998, Vol.29 (1), p.181-181

1998

Volltextzugriff (PDF)

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients: Sulpiride and monoamine metabolite

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.75-92

1984

Volltextzugriff (PDF)

Involvement of central catecholamines in the feedback actions of 17β-estradiolbenzoate on luteinizing hormone secretion in the ovariectomized female rat

Psychoneuroendocrinology, 1977, Vol.2 (3), p.203-225

1977

Volltextzugriff (PDF)

Clinical Evaluation of Sulpiride in Schizophrenic Patients ‐ A Double‐blind Comparison with Chlorpromazine: Sulpiride in schizophrenic

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.7-30

1984

Volltextzugriff (PDF)

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine: Drug concentrations in serum and CSF

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.49-74

1984

Volltextzugriff (PDF)

Unmet needs in persons with long-term psychiatric disabilities

European psychiatry, 2002-05, Vol.17, p.137-137

2002

Volltextzugriff (PDF)

INCREASED CONTENT OF IMMUNOREACTIVE PROSTAGLANDIN E IN CEREBROSPINAL FLUID OF PATIENTS WITH SCHIZOPHRENIA

The Lancet (British edition), 1980-01, Vol.315 (8158), p.16-18

1980

Volltextzugriff (PDF)

Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass gragmentography

Brain research, 1974, Vol.65 (3), p.547-550

1974

Volltextzugriff (PDF)

Studies on dopamine turnover in ovariectomized or hypo-physectomized female rats. effects of 17β-estradiol benzoate, ethynodioldiacetate and ovine prolactin

Brain research, 1978-06, Vol.148 (2), p.399-411

1978

Volltextzugriff (PDF)

Costs for evidence-based care of patients with schizophrenia

European psychiatry, 2002-05, Vol.17, p.149-149

2002

Volltextzugriff (PDF)

LACK OF APPARENT ANTIPSYCHOTIC EFFECT OF THE D-1-DOPAMINE RECEPTOR ANTAGONIST SCH39166 IN ACUTELY ILL SCHIZOPHRENIC-PATIENTS

PSYCHOPHARMACOLOGY, 1995-10, Vol.121 (3), p.309

1995

Volltextzugriff (PDF)

Dopamine-D2 and NMDA glutamate receptors regulate striatal gabaergic transmission differently

Schizophrenia research, 2000-01, Vol.41 (1), p.256

2000

Volltextzugriff (PDF)

Dopamine-D 2 and NMDA glutamate receptors regulate striatal gabaergic transmission differently

Schizophrenia research, 2000, Vol.41 (1), p.256-256

2000

Volltextzugriff (PDF)

Simultaneous mass fragmentographic determination of 3, 4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in brain tissue

Journal of Neural Transmission, 1974-12, Vol.35 (4), p.319-326

1974

Volltextzugriff (PDF)

Reduced energy metabolism in schizophrenia

European psychiatry, 2002-05, Vol.17, p.185-185

2002

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

Niacin skin-flush response and with schizophrenia electrodermal activity in patients and healthy controls

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Schizophrenia as a systemic disorder — studies of peripheral and central biological functions

Muscle histopathology in schizophrenia

Aberrant tyrosine transport across the cell membrane in schizophrenia

Aberrant fingertapping and electromyographical abnormalities in patients with schizophrenia

Muscle biopsy, macro EMG and clinical characteristics in patients with schizophrenia

Association study and meta-analysis of a DRD3 gene Ser9Gly variant and schizophrenia

Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and normals

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients: Sulpiride and monoamine metabolite

Involvement of central catecholamines in the feedback actions of 17β-estradiolbenzoate on luteinizing hormone secretion in the ovariectomized female rat

Clinical Evaluation of Sulpiride in Schizophrenic Patients ‐ A Double‐blind Comparison with Chlorpromazine: Sulpiride in schizophrenic

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine: Drug concentrations in serum and CSF

Unmet needs in persons with long-term psychiatric disabilities

INCREASED CONTENT OF IMMUNOREACTIVE PROSTAGLANDIN E IN CEREBROSPINAL FLUID OF PATIENTS WITH SCHIZOPHRENIA

Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass gragmentography

Studies on dopamine turnover in ovariectomized or hypo-physectomized female rats. effects of 17β-estradiol benzoate, ethynodioldiacetate and ovine prolactin

Costs for evidence-based care of patients with schizophrenia

LACK OF APPARENT ANTIPSYCHOTIC EFFECT OF THE D-1-DOPAMINE RECEPTOR ANTAGONIST SCH39166 IN ACUTELY ILL SCHIZOPHRENIC-PATIENTS

Dopamine-D2 and NMDA glutamate receptors regulate striatal gabaergic transmission differently

Dopamine-D 2 and NMDA glutamate receptors regulate striatal gabaergic transmission differently

Simultaneous mass fragmentographic determination of 3, 4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in brain tissue

Reduced energy metabolism in schizophrenia

Aktive Filter

Suchergebnisse filtern